Cargando…
Comparison of risperidone, olanzapine and quetiapine: effects on body weight, serum blood glucose and prolactin
Schizophrenia is a chronic illness with a lifetime prevalence of 1% and with serious physical, social and economic consequences. Over the past decade, atypical antipsychotic medications have become the first-line treatment for schizophrenia (Breier et al, 2005).
Autores principales: | Chaudhry, Haroon Rashid, Arshad, Nadia, Niaz, Saima, Suleman, Tahir, Mufti, Khalid A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal College of Psychiatrists
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734827/ https://www.ncbi.nlm.nih.gov/pubmed/31507951 |
Ejemplares similares
-
A comparative study of sexual dysfunction involving risperidone, quetiapine, and olanzapine
por: Nagaraj, Anil Kumar M., et al.
Publicado: (2009) -
A 12-year follow-up of a sample of patients dependent upon heroin
por: Niaz, Saima, et al.
Publicado: (2007) -
Anti-depressive effectiveness of olanzapine, quetiapine, risperidone and ziprasidone: a pragmatic, randomized trial
por: Kjelby, Eirik, et al.
Publicado: (2011) -
Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone
por: Johnsen, Erik, et al.
Publicado: (2010) -
Risperidone, quetiapine, and olanzapine adjunctive treatments in major depression with psychotic features: a comparative study
por: Gabriel, A
Publicado: (2013)